Serum surfactant protein D (SP-D) and soluble receptor for advanced glycation end-products (sRAGE) are both promising markers of alveolar epithelial injury which have both been linked to poor prognosis in ARDS [9,10,11]. The gene discussed is SFTPD; the disease is acute respiratory distress syndrome.